Initial evidence of safety and clinical effect of recombinant streptokinase suppository in acute hemorrhoidal disease. Open, proof-of-concept, pilot trial

Initial evidence of safety and clinical effect of recombinant streptokinase suppository in acute hemorrhoidal disease. Open, proof-of-concept, pilot trial

A proof-of-concept, pilot clinical trial was carried out in 2 hospitals, to evaluate the safety of recombinant streptokinase (rSK) administered by the rectal route in patients with acute hemorrhoidal disease (AHD). Suppositories containing 200 000 IU rSK were given every 6 hours, up to 4 application...

Full description

Bibliographic Details
Main Authors: Liván Quintero, Francisco Hernández, Maria Acelia, Carmen María, Manuel López, Silvia Barcelona, Rafael Ibargollín, Hailen Bobillo, Ana Aguilera, Yilian Bermúdez, Rolando Páez, Eduardo Martínez, Herminia Rodríguez, Armando Aguiar, Ramón Ramírez, Pedro López
Format: Article
Language:English
Published: Elfos Scientiae
Series:Biotecnología Aplicada
Subjects:
streptokinase
thrombolysis
suppository
hemorrhoidal crisis
Online Access:http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1027-28522010000400003&lng=en&tlng=en

Internet

http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1027-28522010000400003&lng=en&tlng=en

Similar Items